Detalles de la búsqueda
1.
Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis.
J Antimicrob Chemother
; 78(3): 810-816, 2023 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738250
2.
In Vitro and In Vivo Characterization of Tebipenem (TBP), an Orally Active Carbapenem, against Biothreat Pathogens.
Antimicrob Agents Chemother
; 65(5)2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593844
3.
Demonstration of the broad spectrum in vitro activity of finafloxacin against pathogens of biodefence interest.
Antimicrob Agents Chemother
; 63(12)2019 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570393
4.
In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28223382
5.
In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum ß-lactamase inhibitor, against biothreat and ESKAPE pathogens.
J Antibiot (Tokyo)
; 74(12): 884-892, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34522025
6.
Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against Yersinia pestis Infection in a Bubonic Plague Model.
Antibodies (Basel)
; 9(3)2020 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32756297
7.
Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo.
Front Chem
; 6: 309, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30155456
Resultados
1 -
7
de 7
1
Próxima >
>>